Dr. Fabian Kruse is a senior associate in CRA’s Munich office.
Fabian has expertise across a broad spectrum of projects revolving around patient finding in rare diseases, pricing & market access, and competitive strategies. Through various engagements supporting biotech and pharmaceutical companies, Fabian has gained significant experience with both rare and ultra-orphan diseases, but also more common therapy areas, spanning across genetic diseases, oncology, and respiratory diseases. On projects, Fabian manages and works on day-to-day activities to deliver project milestones.
Prior to joining CRA’s Life Sciences Practice, he conducted his PhD on Genetics at Utrecht University in the Netherlands with a focus on regenerative therapies for cardiovascular conditions.
PhD, Genetics, Utrecht University in the Netherlands